Cargando…

Melatonin Effects on EEG Activity During Sleep Onset in Mild-to-Moderate Alzheimer’s Disease: A Pilot Study

There is evidence demonstrating that 5-mg of fast-release melatonin significantly reduces nocturnal sleep onset in patients with mild-to-moderate Alzheimer’s disease (AD). However, the physiological mechanism that could promote sleep installation by melatonin in patients with AD is still poorly unde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cruz-Aguilar, Manuel Alejandro, Ramírez-Salado, Ignacio, Guevara, Miguel Angel, Hernández-González, Marisela, Benitez-King, Gloria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159690/ https://www.ncbi.nlm.nih.gov/pubmed/30480249 http://dx.doi.org/10.3233/ADR-170019

Ejemplares similares

Home EEG sleep assessment shows reduced slow‐wave sleep in mild–moderate Alzheimer's disease
por: Kent, Brianne A., et al.
Publicado: (2022)

EEG alterations during wake and sleep in mild cognitive impairment and Alzheimer's disease
por: D'Atri, Aurora, et al.
Publicado: (2021)

Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer’s disease: a 6-month, randomized, placebo-controlled, multicenter trial
por: Wade, Alan G, et al.
Publicado: (2014)

Resting-state EEG datasets of adolescents with mild, minimal, and moderate depression
por: Rachamanee, Saravut, et al.
Publicado: (2021)

Characteristics of falls in mild and moderate Alzheimer’s disease
por: Kato-Narita, Eliane Mayumi, et al.
Publicado: (2009)

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
por: Seltzer, Ben
Publicado: (2010)

Neuropsychological Rehabilitation in Mild and Moderate Alzheimer’s Disease Patients
por: Ávila, Renata, et al.
Publicado: (2007)

The conceptual relevance of assessment measures in patients with mild/mild-moderate Alzheimer's disease
por: Hartry, Ann, et al.
Publicado: (2018)

Melatonin: A Neurotrophic Factor?
por: Miranda-Riestra, Armida, et al.
Publicado: (2022)

Increased EEG gamma band activity in Alzheimer’s disease and mild cognitive impairment
por: van Deursen, J. A., et al.
Publicado: (2008)

Robust Assessment of EEG Connectivity Patterns in Mild Cognitive Impairment and Alzheimer's Disease
por: Clark, Ruaridh A., et al.
Publicado: (2022)

Estimating attrition in mild-to-moderate Alzheimer’s disease and mild cognitive impairment clinical trials
por: Ritchie, Marina, et al.
Publicado: (2023)

Changes during the sleep onset process on EEG activity and the components of attention
por: Borrani, Jorge, et al.
Publicado: (2022)

Effect of TTP488 in patients with mild to moderate Alzheimer’s disease
por: Burstein, Aaron H, et al.
Publicado: (2014)

Enrichment factors for clinical trials in mild-to-moderate Alzheimer's disease
por: Ballard, Clive, et al.
Publicado: (2019)

Dysphagia is closely related to frailty in mild-to-moderate Alzheimer’s disease
por: Güner, Merve, et al.
Publicado: (2023)

Melatonin in Alzheimer’s Disease
por: Lin, Li, et al.
Publicado: (2013)

The circadian rest-activity pattern predicts cognitive decline among mild-moderate Alzheimer’s disease patients
por: Targa, Adriano D. S., et al.
Publicado: (2021)

Automated Multiclass Classification of Spontaneous EEG Activity in Alzheimer’s Disease and Mild Cognitive Impairment
por: Ruiz-Gómez, Saúl J., et al.
Publicado: (2018)

Sleep EEG-Based Approach to Detect Mild Cognitive Impairment
por: Geng, Duyan, et al.
Publicado: (2022)

Melatonin Moderates the Triangle of Chronic Pain, Sleep Architecture and Immunometabolic Traffic
por: Chaudhry, Shafqat R., et al.
Publicado: (2021)

The Prediction of Response to Galantamine Treatment in Patients with Mild to Moderate Alzheimer’s Disease
por: Ohnishi, Takashi, et al.
Publicado: (2014)

Probabilistic Cost-Effectiveness Analysis of Vaccination for Mild or Moderate Alzheimer’s Disease
por: Yang, Kuen-Cheh, et al.
Publicado: (2016)

Multiple-dose ponezumab for mild-to-moderate Alzheimer's disease: Safety and efficacy
por: Landen, Jaren W., et al.
Publicado: (2017)

Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial
por: Lawlor, Brian, et al.
Publicado: (2018)

Heterogeneity in Cost-Effectiveness Analysis of Vaccination for Mild and Moderate Alzheimer’s Disease
por: Lin, Chung-Hsien, et al.
Publicado: (2019)

Cost-effectiveness analysis of the treatment of mild and moderate Alzheimer’s disease in Brazil
por: da Silva, Luciana R., et al.
Publicado: (2018)

Safety and tolerability of GRF6019 in mild‐to‐moderate Alzheimer's disease dementia
por: Hannestad, Jonas, et al.
Publicado: (2020)

Efficacy of Liposomal Melatonin in sleep EEG in Childhood: A Double Blind Case Control Study
por: Bonuccelli, Alice, et al.
Publicado: (2022)

Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer’s disease
por: Rijpma, Anne, et al.
Publicado: (2015)

Specific EEG Changes Associated with Atrophy of Hippocampus in Subjects with Mild Cognitive Impairment and Alzheimer's Disease
por: Moretti, D. V., et al.
Publicado: (2012)

Novelty detection-based approach for Alzheimer’s disease and mild cognitive impairment diagnosis from EEG
por: Cejnek, Matous, et al.
Publicado: (2021)

Resting state EEG biomarkers of cognitive decline associated with Alzheimer’s disease and mild cognitive impairment
por: Meghdadi, Amir H., et al.
Publicado: (2021)

Neural biomarker diagnosis and prediction to mild cognitive impairment and Alzheimer’s disease using EEG technology
por: Jiao, Bin, et al.
Publicado: (2023)

Neuropsychological Evaluation and Quantitative EEG in Patients with Frontotemporal Dementia, Alzheimer’s Disease, and Mild Cognitive Impairment
por: Tomasello, Letteria, et al.
Publicado: (2023)

Positive effect of timed blue-enriched white light on sleep and cognition in patients with mild and moderate Alzheimer’s disease
por: Kim, Seong Jae, et al.
Publicado: (2021)

The Regional EEG Pattern of the Sleep Onset Process in Older Adults
por: Gorgoni, Maurizio, et al.
Publicado: (2021)

Retrospective case studies of the efficacy of caprylic triglyceride in mild-to-moderate Alzheimer’s disease
por: Maynard, Steven Douglas, et al.
Publicado: (2013)

Analysis of word number and content in discourse of patients with mild to moderate Alzheimer's disease
por: de Lira, Juliana Onofre, et al.
Publicado: (2014)

Acupuncture for patients with mild to moderate Alzheimer’s disease: a randomized controlled trial
por: Jia, Yujie, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_chbsqj5h16cqtr8mlic1ellip0